Back
iShares LifePath Target Date 2040 ETF Vs. Cidara Therapeutics Industry Stock Comparison
Buy
55
ITDD
iShares LifePath Target Date 2040 ETF
Last Price:
$34.01
Seasonality Move:
4.77%
Buy
69
CDTX
Cidara Therapeutics
Last Price:
$61.97
Seasonality Move:
-6.02%
Buy
55
iShares LifePath Target Date 2040 ETF (ITDD)
is a Buy
Is iShares LifePath Target Date 2040 ETF a Buy, Sell or Hold?
-
The current iShares LifePath Target Date 2040 ETF [ITDD] share price is $33.33. The Score for ITDD is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
-
ITDD is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
69
Cidara Therapeutics (CDTX)
is a Buy
Is Cidara Therapeutics a Buy, Sell or Hold?
-
The current Cidara Therapeutics [CDTX] share price is $61.77. The Score for CDTX is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
-
CDTX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ITDD Stock Price Chart
What is iShares LifePath Target Date 2040 ETF's stock price today?
-
The iShares LifePath Target Date 2040 ETF share price today is $33.33Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITDD is experiencing slight selling pressure.
CDTX Stock Price Chart
What is Cidara Therapeutics's stock price today?
-
The Cidara Therapeutics share price today is $61.77Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing slight buying pressure.
ITDD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 8.76 | Buy |
Relative Strength Index (14 RSI): | 57 | Buy |
Chaikin Money Flow: | -2295 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (33.03 - 33.43) | Buy |
Bollinger Bands (100): | (30.19 - 32.97) | Buy |
CDTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 16.41 | Buy |
Relative Strength Index (14 RSI): | 66.13 | Buy |
Chaikin Money Flow: | 107372 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (50.82 - 62.54) | Buy |
Bollinger Bands (100): | (16.01 - 47.93) | Buy |
ITDD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 33.35 | Sell |
20-day SMA: | 33.28 | Buy |
50-day SMA: | 32.72 | Buy |
200-day SMA: | 31.4 | Buy |
8-day EMA: | 25.91 | Buy |
20-day EMA: | 15.03 | Buy |
50-day EMA: | 7.1 | Buy |
200-day EMA: | 1.94 | Buy |
CDTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 62.34 | Sell |
20-day SMA: | 58.63 | Buy |
50-day SMA: | 42.99 | Buy |
200-day SMA: | 25.81 | Buy |
8-day EMA: | 48.54 | Buy |
20-day EMA: | 28.15 | Buy |
50-day EMA: | 13.31 | Buy |
200-day EMA: | 3.63 | Buy |
iShares LifePath Target Date 2040 ETF Earnings Growth & ITDD Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Cidara Therapeutics Earnings Growth & CDTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $3.78 per share, a decrease next quarter of $0.00 per share, an increase this year of $15.76 per share, and a decrease next year of $0.53 per share.
iShares LifePath Target Date 2040 ETF Technical Analysis
Jul 23 | Jul 24 | Jul 25 | Jul 28 | Jul 29 | Jul 30 | Jul 31 | Aug 1 | Aug 4 | Aug 5 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | Aug | |||||||||
23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Cidara Therapeutics Technical Analysis
Jul 23 | Jul 24 | Jul 25 | Jul 28 | Jul 29 | Jul 30 | Jul 31 | Aug 1 | Aug 4 | Aug 5 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | Aug | |||||||||
23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |